Back to Search
TOMMI JARVINEN, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1821823287Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (5)
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
PMID 12006526·Clin Cancer Res·2002
3-trial
Cycloserine fatty acid derivatives as prodrugs: synthesis, degradation and in vitro skin permeability.
PMID 11964011·Chem Pharm Bull (Tokyo)·2002
7-preclinical
Synthesis, stability and in vitro dermal evaluation of aminocarbonyloxymethyl esters as prodrugs of carboxylic acid agents.
PMID 11814870·Bioorg Med Chem·2002
8-other
HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide.
PMID 11583189·Ann Oncol·2001
3-trial
Synthesis and in vitro/in vivo evaluation of novel oral N-alkyl- and N,N-dialkyl-carbamate esters of entacapone.
PMID 10901288·Life Sci·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2301 ERWIN RD
DURHAM, NC 27705 - Phone
- (919) 684-8111
Quick Facts
- NPI
- 1821823287
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile